<DOC>
	<DOCNO>NCT01822860</DOCNO>
	<brief_summary>Chlorthalidone result improve endothelial function compare hydrochlorothiazide measure flow mediate vasodilatation .</brief_summary>
	<brief_title>Chlorthalidone Compared Hydrochlorothiazide Endothelial Function</brief_title>
	<detailed_description>This randomize , double-blind , crossover study evaluate chlorthalidone hydrochlorothiazide effect endothelial function hypertensive patient . Subjects receive chlorthalidone 12.5 mg , hydrochlorothiazide 25 mg , placebo 4 week 1 week washout study period . Sequence study drug randomize . Flow mediate vasodilatation measure baseline treatment period .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Age 19 old Diagnosis hypertension Current blood pressure &gt; 120/80 mm Hg Use thiazidetype diuretic within last 1 month Known allergy study medication History gout hyperuricemia SCr &gt; /= 1.8 mg/dl CrCl &lt; 25 ml/min Pregnancy breastfeed plan become pregnant study period Dementia cognitive impairment Hypokalemia Acute coronary syndrome stroke within 6 month Current use sildenafil , tadalafil , vardenafil</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Endothelial dysfunction</keyword>
</DOC>